Will an oncoStem hospital-use kit allow for wider access to breast cancer risk tests?

The new kit, which uses a decentralized approach and lower logistics, is expected to boost hospital adoption of personalised treatment.

• Option 1: Wider access will help the company grow faster
• Option 2: OncoStem expects wider access to mean increased revenue and jobs